|
Kulis has over 15 years of experience successfully leading and executing regulatory strategies and clinical trials for a variety of interventional cardiology devices. Most recently, she was Vice President of Regulatory and Clinical Affairs for NMT Medical, Inc., a developer and marketer of cardiac implants and catheter-based delivery systems. Kulis' career also included executive positions with C.R. Bard, Inc., including Vice President, Regulatory and Clinical Affairs of the Bard Myocardial Angiogenesis Group and Staff Vice President, Regulatory Affairs of Bard Cardiology.
Kulis received her B.S. in Business Administration from New Hampshire College. | 